Home Newsfeeds Greenlight Biosciences And Epivax Therapeutics Signed Exclusive Collaboration Agreement To Develop Personalized Cancer Vaccines

Greenlight Biosciences And Epivax Therapeutics Signed Exclusive Collaboration Agreement To Develop Personalized Cancer Vaccines

GreenLight Biosciences Holdings, PBC (Nasdaq: GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.

byCharles Gross

January 9, 2023

1 minute read

GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.

News

MaxLinear AnyWAN Expanded to Fiber Home Gateway Units and Fixed Wireless Access Applications

By Benzinga Newsdesk

February 27, 3:46 AM

MaxLinear, Inc. (NASDAQ:MXL), a leader in home gateway solutions that unlock multi-gig home connectivity, today announced that its highly-integrated AnyWAN home gateway SoC has been certified for XGS-PON and

MXL

US Government Seeks AI Client List From Amazon, Alphabet And Microsoft Amid Escalating Tech Tensions With China

By Ananya Gairola

January 28, 11:45 PM

The U.S. government is considering a rule requiring cloud service providers like Amazon, Alphabet, and Microsoft to disclose foreign clients using their services for AI development, in an effort to address national security concerns, particularly with China.

AMZN

Why Is Cancer Firm Kinnate Biopharma Stock Trading Lower Today?

By Vandana Singh

September 19, 9:15 AM

Kinnate Biopharma Inc (NASDAQ: KNTE) announced pipeline updates, a reprioritization plan, and workforce restructuring to

KNTE

Smith Micro Executes New Digital Family Safety Contract With Tier 1 U.S. Mobile Network Operator; No Financial Terms Disclosed

By Benzinga Newsdesk

January 17, 10:26 AM

(NASDAQ:SMSI), Smith Micro Software, Inc., today announced that the Company has entered into a new contract with a leading mobile network operator in the U.S. to continue to provide digital family safety solutions. The

SMSI

Greenlight Biosciences And Epivax Therapeutics Signed Exclusive Collaboration Agreement To Develop Personalized Cancer Vaccines

Related Posts

MaxLinear AnyWAN Expanded to Fiber Home Gateway Units and Fixed Wireless Access Applications

US Government Seeks AI Client List From Amazon, Alphabet And Microsoft Amid Escalating Tech Tensions With China

Why Is Cancer Firm Kinnate Biopharma Stock Trading Lower Today?

Smith Micro Executes New Digital Family Safety Contract With Tier 1 U.S. Mobile Network Operator; No Financial Terms Disclosed